APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Nutritional Product

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Nutritional Product Market Outlook and Growth Opportunities 2026

29 December 2025202 pages

Choose your research edition.

Industry ResearchIntravenous Nutritional Product Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Nutritional Product Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intravenous Nutritional Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Nutritional Product Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Nutritional Product Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Intravenous Nutritional Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intravenous Nutritional Product market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intravenous Nutritional Product market include Xi'an Libang Pharmaceutical, Weixinkang, B. Braun, Baxter, Otsuka Pharmaceutical, Lummy, Lionco Pharmaceutical, King York and Kelun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Intravenous Nutritional Product market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Nutritional Product and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Nutritional Product revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Intravenous Nutritional Product market.

Intravenous Nutritional Product Segment by Company

Xi'an Libang Pharmaceutical

Weixinkang

B. Braun

Baxter

Otsuka Pharmaceutical

Lummy

Lionco Pharmaceutical

King York

Kelun Pharma

JW Pharmaceutical

Haisco Pharmaceutical Group

Grifols

Grand Life Sciences

Fresenius Kabi

Cisen

China Meheco Kangli

Biokin Pharmaceutical

BBCA Pharmaceutical

Baizheng Pharmaceutical

Aguettant

Intravenous Nutritional Product Segment by Type

Amino Acid

Alanyl-Glutamine

Heat and Fat Emulsion

Trace Elements

Vitamins

Intravenous Nutritional Product Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Others

Intravenous Nutritional Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Nutritional Product status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Intravenous Nutritional Product key companies, revenue, market share, and recent developments.

3. To split the Intravenous Nutritional Product breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Intravenous Nutritional Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Nutritional Product significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Nutritional Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Nutritional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Nutritional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Nutritional Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Nutritional Product industry.

Chapter 3: Detailed analysis of Intravenous Nutritional Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Intravenous Nutritional Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Intravenous Nutritional Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Nutritional Product Industry Trends Table 2. Intravenous Nutritional Product Industry Drivers Table 3. Intravenous Nutritional Product Industry Opportunities and Challenges Table 4. Intravenous Nutritional Product Industry Restraints Table 5. Global Intravenous Nutritional Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Nutritional Product Revenue Share by Company (2021-2026) Table 7. Global Intravenous Nutritional Product Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Intravenous Nutritional Product Key Company Manufacturing Base & Headquarters Table 9. Global Intravenous Nutritional Product Company, Product Type & Application Table 10. Global Intravenous Nutritional Product Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Intravenous Nutritional Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Amino Acid Table 15. Significant Companies of Alanyl-Glutamine Table 16. Significant Companies of Heat and Fat Emulsion Table 17. Significant Companies of Trace Elements Table 18. Significant Companies of Vitamins Table 19. Global Intravenous Nutritional Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Intravenous Nutritional Product Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Intravenous Nutritional Product Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Intravenous Nutritional Product Sales Value Share by Type (2021-2026) Table 23. Global Intravenous Nutritional Product Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Pharmacies Table 25. Significant Companies of Online Pharmacies Table 26. Significant Companies of Retail Pharmacies Table 27. Significant Companies of Others Table 28. Global Intravenous Nutritional Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Intravenous Nutritional Product Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Intravenous Nutritional Product Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Intravenous Nutritional Product Sales Value Share by Application (2021-2026) Table 32. Global Intravenous Nutritional Product Sales Value Share by Application (2027-2032) Table 33. Global Intravenous Nutritional Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Intravenous Nutritional Product Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Intravenous Nutritional Product Sales Value Share by Region (2021-2026) Table 36. Global Intravenous Nutritional Product Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Intravenous Nutritional Product Sales Value Share by Region (2027-2032) Table 38. Global Intravenous Nutritional Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Intravenous Nutritional Product Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Intravenous Nutritional Product Sales Value Market Share by Country (2021-2026) Table 41. Global Intravenous Nutritional Product Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Intravenous Nutritional Product Sales Value Market Share by Country (2027-2032) Table 43. Xi'an Libang Pharmaceutical Company Information Table 44. Xi'an Libang Pharmaceutical Business Overview Table 45. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 47. Xi'an Libang Pharmaceutical Recent Development Table 48. Weixinkang Company Information Table 49. Weixinkang Business Overview Table 50. Weixinkang Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Weixinkang Intravenous Nutritional Product Product Portfolio Table 52. Weixinkang Recent Development Table 53. B. Braun Company Information Table 54. B. Braun Business Overview Table 55. B. Braun Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. B. Braun Intravenous Nutritional Product Product Portfolio Table 57. B. Braun Recent Development Table 58. Baxter Company Information Table 59. Baxter Business Overview Table 60. Baxter Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Baxter Intravenous Nutritional Product Product Portfolio Table 62. Baxter Recent Development Table 63. Otsuka Pharmaceutical Company Information Table 64. Otsuka Pharmaceutical Business Overview Table 65. Otsuka Pharmaceutical Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 67. Otsuka Pharmaceutical Recent Development Table 68. Lummy Company Information Table 69. Lummy Business Overview Table 70. Lummy Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lummy Intravenous Nutritional Product Product Portfolio Table 72. Lummy Recent Development Table 73. Lionco Pharmaceutical Company Information Table 74. Lionco Pharmaceutical Business Overview Table 75. Lionco Pharmaceutical Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 77. Lionco Pharmaceutical Recent Development Table 78. King York Company Information Table 79. King York Business Overview Table 80. King York Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. King York Intravenous Nutritional Product Product Portfolio Table 82. King York Recent Development Table 83. Kelun Pharma Company Information Table 84. Kelun Pharma Business Overview Table 85. Kelun Pharma Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Kelun Pharma Intravenous Nutritional Product Product Portfolio Table 87. Kelun Pharma Recent Development Table 88. JW Pharmaceutical Company Information Table 89. JW Pharmaceutical Business Overview Table 90. JW Pharmaceutical Intravenous Nutritional Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. JW Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 92. JW Pharmaceutical Recent Development Table 93. Haisco Pharmaceutical Group Company Information Table 94. Haisco Pharmaceutical Group Business Overview Table 95. Haisco Pharmaceutical Group Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio Table 97. Haisco Pharmaceutical Group Recent Development Table 98. Grifols Company Information Table 99. Grifols Business Overview Table 100. Grifols Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Grifols Intravenous Nutritional Product Product Portfolio Table 102. Grifols Recent Development Table 103. Grand Life Sciences Company Information Table 104. Grand Life Sciences Business Overview Table 105. Grand Life Sciences Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Grand Life Sciences Intravenous Nutritional Product Product Portfolio Table 107. Grand Life Sciences Recent Development Table 108. Fresenius Kabi Company Information Table 109. Fresenius Kabi Business Overview Table 110. Fresenius Kabi Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Fresenius Kabi Intravenous Nutritional Product Product Portfolio Table 112. Fresenius Kabi Recent Development Table 113. Cisen Company Information Table 114. Cisen Business Overview Table 115. Cisen Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Cisen Intravenous Nutritional Product Product Portfolio Table 117. Cisen Recent Development Table 118. China Meheco Kangli Company Information Table 119. China Meheco Kangli Business Overview Table 120. China Meheco Kangli Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. China Meheco Kangli Intravenous Nutritional Product Product Portfolio Table 122. China Meheco Kangli Recent Development Table 123. Biokin Pharmaceutical Company Information Table 124. Biokin Pharmaceutical Business Overview Table 125. Biokin Pharmaceutical Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 127. Biokin Pharmaceutical Recent Development Table 128. BBCA Pharmaceutical Company Information Table 129. BBCA Pharmaceutical Business Overview Table 130. BBCA Pharmaceutical Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 132. BBCA Pharmaceutical Recent Development Table 133. Baizheng Pharmaceutical Company Information Table 134. Baizheng Pharmaceutical Business Overview Table 135. Baizheng Pharmaceutical Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 137. Baizheng Pharmaceutical Recent Development Table 138. Aguettant Company Information Table 139. Aguettant Business Overview Table 140. Aguettant Intravenous Nutritional Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Aguettant Intravenous Nutritional Product Product Portfolio Table 142. Aguettant Recent Development Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Intravenous Nutritional Product Product Image Figure 2. Global Intravenous Nutritional Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Nutritional Product Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Amino Acid Image Figure 8. Alanyl-Glutamine Image Figure 9. Heat and Fat Emulsion Image Figure 10. Trace Elements Image Figure 11. Vitamins Image Figure 12. Global Intravenous Nutritional Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Intravenous Nutritional Product Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Intravenous Nutritional Product Sales Value Share by Type (2021-2032) Figure 15. Hospital Pharmacies Image Figure 16. Online Pharmacies Image Figure 17. Retail Pharmacies Image Figure 18. Others Image Figure 19. Global Intravenous Nutritional Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Intravenous Nutritional Product Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Intravenous Nutritional Product Sales Value Share by Application (2021-2032) Figure 22. Global Intravenous Nutritional Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Intravenous Nutritional Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Intravenous Nutritional Product Sales Value (2021-2032) & (US$ Million) Figure 25. North America Intravenous Nutritional Product Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Intravenous Nutritional Product Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Intravenous Nutritional Product Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Intravenous Nutritional Product Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Intravenous Nutritional Product Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Intravenous Nutritional Product Sales Value (2021-2032) & (US$ Million) Figure 31. South America Intravenous Nutritional Product Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Intravenous Nutritional Product Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Intravenous Nutritional Product Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Intravenous Nutritional Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acid
  • Alanyl-Glutamine
  • Heat and Fat Emulsion
  • Trace Elements
  • Vitamins
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Xi'an Libang Pharmaceutical
  • Weixinkang
  • B. Braun
  • Baxter
  • Otsuka Pharmaceutical
  • Lummy
  • Lionco Pharmaceutical
  • King York
  • Kelun Pharma
  • JW Pharmaceutical
  • Haisco Pharmaceutical Group
  • Grifols
  • Grand Life Sciences
  • Fresenius Kabi
  • Cisen
  • China Meheco Kangli
  • Biokin Pharmaceutical
  • BBCA Pharmaceutical
  • Baizheng Pharmaceutical
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Nutritional Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Nutritional Product Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Intravenous Nutritional Product Market Dynamics
  1. 2.1 Intravenous Nutritional Product Industry Trends
  2. 2.2 Intravenous Nutritional Product Industry Drivers
  3. 2.3 Intravenous Nutritional Product Industry Opportunities and Challenges
  4. 2.4 Intravenous Nutritional Product Industry Restraints
3 Intravenous Nutritional Product Market by Company
  1. 3.1 Global Intravenous Nutritional Product Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Nutritional Product Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Nutritional Product Company Ranking (2024-2026)
  4. 3.4 Global Intravenous Nutritional Product Company Manufacturing Base and Headquarters
  5. 3.5 Global Intravenous Nutritional Product Company Product Type and Application
  6. 3.6 Global Intravenous Nutritional Product Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Intravenous Nutritional Product Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Intravenous Nutritional Product Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Intravenous Nutritional Product Market by Type
  1. 4.1 Intravenous Nutritional Product Type Introduction
  2. 4.1.1 Amino Acid
  3. 4.1.2 Alanyl-Glutamine
  4. 4.1.3 Heat and Fat Emulsion
  5. 4.1.4 Trace Elements
  6. 4.1.5 Vitamins
  7. 4.2 Global Intravenous Nutritional Product Sales Value by Type
  8. 4.2.1 Global Intravenous Nutritional Product Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Intravenous Nutritional Product Sales Value by Type (2021-2032)
  10. 4.2.3 Global Intravenous Nutritional Product Sales Value Share by Type (2021-2032)
5 Intravenous Nutritional Product Market by Application
  1. 5.1 Intravenous Nutritional Product Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Intravenous Nutritional Product Sales Value by Application
  7. 5.2.1 Global Intravenous Nutritional Product Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intravenous Nutritional Product Sales Value by Application (2021-2032)
  9. 5.2.3 Global Intravenous Nutritional Product Sales Value Share by Application (2021-2032)
6 Intravenous Nutritional Product Regional Value Analysis
  1. 6.1 Global Intravenous Nutritional Product Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Nutritional Product Sales Value by Region (2021-2032)
  3. 6.2.1 Global Intravenous Nutritional Product Sales Value by Region: 2021-2026
  4. 6.2.2 Global Intravenous Nutritional Product Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Nutritional Product Sales Value (2021-2032)
  7. 6.3.2 North America Intravenous Nutritional Product Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Intravenous Nutritional Product Sales Value (2021-2032)
  10. 6.4.2 Europe Intravenous Nutritional Product Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Intravenous Nutritional Product Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Intravenous Nutritional Product Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Intravenous Nutritional Product Sales Value (2021-2032)
  16. 6.6.2 South America Intravenous Nutritional Product Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Intravenous Nutritional Product Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Intravenous Nutritional Product Sales Value Share by Country, 2025 VS 2032
7 Intravenous Nutritional Product Country-level Value Analysis
  1. 7.1 Global Intravenous Nutritional Product Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Nutritional Product Sales Value by Country (2021-2032)
  3. 7.2.1 Global Intravenous Nutritional Product Sales Value by Country (2021-2026)
  4. 7.2.2 Global Intravenous Nutritional Product Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Intravenous Nutritional Product Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Intravenous Nutritional Product Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Intravenous Nutritional Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi'an Libang Pharmaceutical
  2. 8.1.1 Xi'an Libang Pharmaceutical Company Information
  3. 8.1.2 Xi'an Libang Pharmaceutical Business Overview
  4. 8.1.3 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio
  6. 8.1.5 Xi'an Libang Pharmaceutical Recent Developments
  7. 8.2 Weixinkang
  8. 8.2.1 Weixinkang Company Information
  9. 8.2.2 Weixinkang Business Overview
  10. 8.2.3 Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Weixinkang Intravenous Nutritional Product Product Portfolio
  12. 8.2.5 Weixinkang Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Intravenous Nutritional Product Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Intravenous Nutritional Product Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Otsuka Pharmaceutical
  26. 8.5.1 Otsuka Pharmaceutical Company Information
  27. 8.5.2 Otsuka Pharmaceutical Business Overview
  28. 8.5.3 Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio
  30. 8.5.5 Otsuka Pharmaceutical Recent Developments
  31. 8.6 Lummy
  32. 8.6.1 Lummy Company Information
  33. 8.6.2 Lummy Business Overview
  34. 8.6.3 Lummy Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lummy Intravenous Nutritional Product Product Portfolio
  36. 8.6.5 Lummy Recent Developments
  37. 8.7 Lionco Pharmaceutical
  38. 8.7.1 Lionco Pharmaceutical Company Information
  39. 8.7.2 Lionco Pharmaceutical Business Overview
  40. 8.7.3 Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio
  42. 8.7.5 Lionco Pharmaceutical Recent Developments
  43. 8.8 King York
  44. 8.8.1 King York Company Information
  45. 8.8.2 King York Business Overview
  46. 8.8.3 King York Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  47. 8.8.4 King York Intravenous Nutritional Product Product Portfolio
  48. 8.8.5 King York Recent Developments
  49. 8.9 Kelun Pharma
  50. 8.9.1 Kelun Pharma Company Information
  51. 8.9.2 Kelun Pharma Business Overview
  52. 8.9.3 Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kelun Pharma Intravenous Nutritional Product Product Portfolio
  54. 8.9.5 Kelun Pharma Recent Developments
  55. 8.10 JW Pharmaceutical
  56. 8.10.1 JW Pharmaceutical Company Information
  57. 8.10.2 JW Pharmaceutical Business Overview
  58. 8.10.3 JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JW Pharmaceutical Intravenous Nutritional Product Product Portfolio
  60. 8.10.5 JW Pharmaceutical Recent Developments
  61. 8.11 Haisco Pharmaceutical Group
  62. 8.11.1 Haisco Pharmaceutical Group Company Information
  63. 8.11.2 Haisco Pharmaceutical Group Business Overview
  64. 8.11.3 Haisco Pharmaceutical Group Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio
  66. 8.11.5 Haisco Pharmaceutical Group Recent Developments
  67. 8.12 Grifols
  68. 8.12.1 Grifols Company Information
  69. 8.12.2 Grifols Business Overview
  70. 8.12.3 Grifols Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Grifols Intravenous Nutritional Product Product Portfolio
  72. 8.12.5 Grifols Recent Developments
  73. 8.13 Grand Life Sciences
  74. 8.13.1 Grand Life Sciences Company Information
  75. 8.13.2 Grand Life Sciences Business Overview
  76. 8.13.3 Grand Life Sciences Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Grand Life Sciences Intravenous Nutritional Product Product Portfolio
  78. 8.13.5 Grand Life Sciences Recent Developments
  79. 8.14 Fresenius Kabi
  80. 8.14.1 Fresenius Kabi Company Information
  81. 8.14.2 Fresenius Kabi Business Overview
  82. 8.14.3 Fresenius Kabi Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fresenius Kabi Intravenous Nutritional Product Product Portfolio
  84. 8.14.5 Fresenius Kabi Recent Developments
  85. 8.15 Cisen
  86. 8.15.1 Cisen Company Information
  87. 8.15.2 Cisen Business Overview
  88. 8.15.3 Cisen Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cisen Intravenous Nutritional Product Product Portfolio
  90. 8.15.5 Cisen Recent Developments
  91. 8.16 China Meheco Kangli
  92. 8.16.1 China Meheco Kangli Company Information
  93. 8.16.2 China Meheco Kangli Business Overview
  94. 8.16.3 China Meheco Kangli Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  95. 8.16.4 China Meheco Kangli Intravenous Nutritional Product Product Portfolio
  96. 8.16.5 China Meheco Kangli Recent Developments
  97. 8.17 Biokin Pharmaceutical
  98. 8.17.1 Biokin Pharmaceutical Company Information
  99. 8.17.2 Biokin Pharmaceutical Business Overview
  100. 8.17.3 Biokin Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio
  102. 8.17.5 Biokin Pharmaceutical Recent Developments
  103. 8.18 BBCA Pharmaceutical
  104. 8.18.1 BBCA Pharmaceutical Company Information
  105. 8.18.2 BBCA Pharmaceutical Business Overview
  106. 8.18.3 BBCA Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio
  108. 8.18.5 BBCA Pharmaceutical Recent Developments
  109. 8.19 Baizheng Pharmaceutical
  110. 8.19.1 Baizheng Pharmaceutical Company Information
  111. 8.19.2 Baizheng Pharmaceutical Business Overview
  112. 8.19.3 Baizheng Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio
  114. 8.19.5 Baizheng Pharmaceutical Recent Developments
  115. 8.20 Aguettant
  116. 8.20.1 Aguettant Company Information
  117. 8.20.2 Aguettant Business Overview
  118. 8.20.3 Aguettant Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aguettant Intravenous Nutritional Product Product Portfolio
  120. 8.20.5 Aguettant Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst